Michael G. Ison, MD MS

Professor
Northwestern University Feinberg School of Medicine

Disclosure(s): GlaxoSmithKlein: Grant/Research Support; Pulmocide: Grant/Research Support; Viracor Eurfins: Advisor/Consultant

Dr. Michael Ison completed his Infectious Diseases Fellowship at the University of Virginia. He undertook additional training in Transplant Infectious Diseases at the Massachusetts General Hospital and Harvard Medical School under the mentorship of Dr. Jay A. Fishman. He then joined the faculty of the Divisions of Infectious Diseases and Organ Transplantation at Northwestern University Feinberg School of Medicine in 2005. He is currently the Medical Director of the Transplant & Immunocompromised Host Infectious Diseases Service, Northwestern University Comprehensive Transplant Center and Professor of Medicine and Surgery.

Poster(s):

• 139 - Development of cefiderocol resistance in an Enterobacter hormaechei strain following prolonged antibiotic exposure
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1216 - An Outbreak Investigation of Pulmonary Infections Caused by Mycobacterium abscessus in a Cardiothoracic Transplant Population
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET

• 1454 - Describing the Epidemiology of Nosocomial Respiratory Viral Infections (RVIs) at an Academic Medical Center
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET

• 215a - Use of Viracor Cytomegalovirus T-Cell Immunity Panel (TCIP) to Predict the Risk of Recurrent Cytomegalovirus Infection in Solid Transplant Patients and Guide Appropriate Management
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET